Serine protease-driven entry and S2 ′ cleavage flexibility of feline coronavirus during feline enterocyte infections

Read full text
Authors: Bixia Chen, Luna Vanden Buijs, Nathalie Vanderheijden, Lowiese Desmarets, Jolien Van Cleemput, Hans Nauwynck
Cited by: 4
References: 55

Abstract

Coronaviruses not only hijack host cells to serve as viral factories but also exploit host proteolytic systems to activate their spike (S) protein, the key glycoprotein mediating receptor binding and membrane fusion. Feline coronavirus (FCoV), which initially replicates in the intestinal tract, has evolved to utilize local intestinal proteases for S protein activation. This activation occurs through proteolytic cleavage at specific regions on the S protein, known as cleavage sites (CSs). Two putative CSs have been proposed for FCoV: S1/S2 CS and S2' CS. Through a protease screen, we identified serine proteases as particularly critical for FCoV infection. Notably, three pancreatic serine proteases, chymotrypsin, trypsin, and elastase, enhanced FCoV infection and promoted syncytia formation despite their differing cleavage specificities, suggesting a flexible activation strategy. Furthermore, the membrane-bound serine proteases TMPRSS2 and TMPRSS11D also facilitated infection and syncytia formation in a strain-dependent manner. By analyzing the cleavage profiles of these serine proteases, we experimentally confirmed these two putative CSs on the FCoV S protein and identified additional CSs. Importantly, our analysis revealed a compensatory cleavage mechanism at the S2' CS that maintains spike activation even when mutations disrupt the canonical cleavage motif, underscoring the central role of S2' CS in viral infection. Additionally, an acidic microenvironment is required for efficient infection. Together, these findings illustrate how FCoV adapts to locally available serine proteases to optimize S protein priming and intestinal cell entry.

Fields of Study & Subjects

Animal Virus Infections Studies SARS-CoV-2 and COVID-19 Research Virus-based gene therapy research

Publication details

Journal / source
PLoS Pathogens
Publisher
Public Library of Science (PLoS)
Volume
22
Issue
1
Pages
e1013854–e1013854
Publication date
8 January 2026
Language
EN